--- title: "Ord Minnett Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)" type: "News" locale: "en" url: "https://longbridge.com/en/news/296297905.md" description: "Ord Minnett maintained a Buy rating on Pro Medicus Limited (PMCUF) with a price target of A$230.00. Bell Potter's John Hester also issued a Buy rating for the company. Conversely, Jefferies maintained a Hold rating on PMCUF as of August 13." datetime: "2026-08-19T02:05:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296297905.md) - [en](https://longbridge.com/en/news/296297905.md) - [zh-HK](https://longbridge.com/zh-HK/news/296297905.md) generator: "portal-rs" --- # Ord Minnett Keeps Their Buy Rating on Pro Medicus Limited (PMCUF) In a report released today, from Ord Minnett maintained a Buy rating on Pro Medicus Limited, with a price target of A$230.00. ### Summer Sale - Claim 70% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In addition to Ord Minnett, Pro Medicus Limited also received a Buy from Bell Potter’s John Hester in a report issued today. However, on August 13, Jefferies maintained a Hold rating on Pro Medicus Limited (Other OTC: PMCUF). ### Related Stocks - [PME.AU](https://longbridge.com/en/quote/PME.AU.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) ## Related News & Research - [Citi Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)](https://longbridge.com/en/news/298518238.md) - [Macquarie Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)](https://longbridge.com/en/news/294440398.md) - [Canaccord Genuity Sticks to Its Buy Rating for MaxiPARTS Limited (MXI)](https://longbridge.com/en/news/298181215.md) - [Ord Minnett Remains a Buy on Select Harvests (SHVTF)](https://longbridge.com/en/news/298396403.md) - [Macquarie Reaffirms Their Buy Rating on Megaport (MGPPF)](https://longbridge.com/en/news/298158915.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**